Skip to content

Public FDA record

Z-1463-2024: Ureteral dilator, REF RBD014

Recall record Z-1463-2024 for Coloplast Manufacturing US, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1463-2024
Company in FDA record
Coloplast Manufacturing US, LLC
FDA classification date
Apr 2, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A possible sterility issue (e.g. a breach in sterile packaging) was detected in Coloplast's facility on some ureteral dilator products. This issue on the ureteral dilator packaging has been identified during testing in our facility.

Source facts

Action
Coloplast issued an URGENT MEDICAL DEVICE VOLUNTARY RECALL notice to its consignees on 03/11/2024 via USPS first class mail. The notice explained the issue and requested the consignee contact the firm ( Email: urology@coloplast.com, Phone: 800-258-3476) for a refund for returned product.
Initiated
2024-03-11
Root cause
Under Investigation by firm
Distribution
US: GA, MS, TN, MN, AZ,N MD, LA, KS, WA
Recall number
Z-1463-2024
Recall status
Open, Classified
CDRH record ID
206596
FDA classified
2024-04-02
Recall event number
94218

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗